| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.67▲ | 3.68▼ | 3.68▼ | 3.74▼ | 3.53▲ |
| MA10 | 3.67▲ | 3.68▼ | 3.68▼ | 3.74▼ | 3.28▲ |
| MA20 | 3.68▼ | 3.68▼ | 3.71▼ | 3.48▲ | 3.57▲ |
| MA50 | 3.68▼ | 3.73▼ | 3.75▼ | 3.20▲ | 4.98▼ |
| MA100 | 3.68▼ | 3.74▼ | 3.63▲ | 3.60▲ | 8.39▼ |
| MA200 | 3.72▼ | 3.59▲ | 3.41▲ | 4.66▼ | 29.38▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.002▲ | -0.002▼ | 0.007▲ | 0.180▲ |
| RSI | 46.762▼ | 41.100▼ | 39.607▼ | 62.197▲ | 42.362▼ |
| STOCH | 56.944 | 35.873 | 48.968 | 62.125 | 76.991 |
| WILL %R | -50.000 | -60.000 | -80.952▼ | -19.318▲ | -16.346▲ |
| CCI | 28.571 | -66.094 | -77.778 | 14.071 | 129.513▲ |
|
Tuesday, November 03, 2026 04:00 PM
Four presentations highlight BriaCell’s Bria-OTS+™ cellular immunotherapy platform and BriaPro’s CD80-based immunotherapy programs; In vitro Bria-OTS+ studies demonstrate im ...
|
|
Tuesday, November 03, 2026 08:00 AM
Dagger ® is a trademark of Allogene Therapeutics, Inc.
|
|
Tuesday, November 03, 2026 06:00 AM
Evaxion A/S (NASDAQ: EVAX) will present new biomarker data from its phase 2 trial with personalized cancer vaccine EVX-01 at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/11/26 | 3.67 | 3.71 | 3.645 | 3.67 | 1,781,452 |
| 02/11/26 | 3.73 | 3.7685 | 3.655 | 3.67 | 2,078,829 |
| 30/10/26 | 3.84 | 3.84 | 3.72 | 3.73 | 2,890,097 |
| 29/10/26 | 3.79 | 3.83 | 3.765 | 3.82 | 3,705,859 |
| 28/10/26 | 3.75 | 3.80 | 3.715 | 3.79 | 1,925,690 |
| 27/10/26 | 3.73 | 3.80 | 3.72 | 3.76 | 1,469,456 |
| 26/10/26 | 3.73 | 3.80 | 3.71 | 3.72 | 2,624,878 |
| 23/10/26 | 3.78 | 3.78 | 3.685 | 3.74 | 3,301,218 |
| 22/10/26 | 3.74 | 3.835 | 3.71 | 3.74 | 3,890,777 |
| 21/10/26 | 3.64 | 3.73 | 3.62 | 3.71 | 1,641,391 |
|
|
||||
|
|
||||
|
|